Canton Biologics is the largest Contract Development and Manufacturing Organization (CDMO) in South China, specialising in providing comprehensive, one-stop integrated solutions that adhere to international regulatory standards. Their services span the entire spectrum from early discovery to commercialisation, catering to the needs of global innovative pharmaceutical enterprises. With a leading end-to-end biologics Chemistry, Manufacturing, and Controls (CMC) platform, Canton Biologics excels in areas such as antibody optimisation, cell line and process development, physicochemical and biochemical characterisation, tech-transfer, and clinical bioanalysis. Their commercial manufacturing capabilities encompass 12+4 manufacturing lines that comply with GMP standards of China, the US, and the EU, with production scales ranging from 50 to 2000L using various methods including batch, fed-batch, and perfusion.

Services include:
– Protein and Peptide
– Injectables
– Clinical Dose
– Packaging
– Clinical Packaging

Canton Biologics remains committed to delivering high-quality services tailored to the unique needs of their clients within the pharmaceutical industry. For more information, visit cantonbio.com.